Netarsudil Dimesylate OverviewNetarsudil (trade name Rhopressa) is a drug for the treatment of glaucoma. In the United States in 2017 the Food and Drug Administration approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It targets the trabecular meshwork directly.[failed verification] References ^ "Aerie (AERI) Gets Early FDA Approval for Lead Drug Rhopressa". December...
Read more Netarsudil Dimesylate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Netarsudil
Recent Netarsudil Dimesylate Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution/drops: 0.02%
Other drugs which contain Netarsudil Dimesylate or a similar ingredient: (3 results)
- RHOPRESSA Netarsudil Dimesylate
- LATANOPROST + NETARSUDIL DIMESYLATE
- ROCKLATAN Latanoprost + Netarsudil Dimesylate